Overview
Routine cardiac surveillance is one of the most important elements of Alström care. Both the infant cardiomyopathy and the adolescent/adult cardiomyopathy patterns can develop without obvious early symptoms, so monitoring is how problems get caught early enough to act on. This article summarizes the recommended cardiac monitoring schedule across the lifespan, based on the 2020 international consensus management guidelines.¹
Why monitor
Cardiomyopathy in Alström can:
- Develop quietly before symptoms appear
- Progress while everyday life feels normal
- Decompensate in response to other illnesses, surgeries, or pregnancies
- Be substantially modified by early treatment
Annual or more frequent surveillance gives the cardiology team a chance to act before complications develop.
At diagnosis
When Alström Syndrome is first confirmed, a baseline cardiac evaluation is recommended even if there are no cardiac symptoms. This includes:
- Echocardiogram — assesses chamber size, wall thickness, valve function, ejection fraction
- EKG (12-lead) — assesses rhythm and electrical conduction
- Clinical history and exam — identifies any subtle symptoms
Baseline studies become the reference for future comparisons.
Infants and young children (0–5)
For children with Alström — particularly those who experienced infant cardiomyopathy:
- Echocardiogram every 6–12 months during the recovery phase
- Annual EKG
- More frequent monitoring if cardiomyopathy is active or recovery is incomplete
For children whose initial echo is normal, annual echocardiograms continue throughout childhood as surveillance.
School-age children (5–12)
After recovery from infant cardiomyopathy and during the period of relative cardiac stability:
- Annual echocardiogram
- Annual EKG
- Periodic 24-hour Holter monitor if rhythm concerns exist
- Cardiac MRI every 2–5 years for some patients
Active heart medications continue under cardiologist supervision.
Adolescents (13–18)
The teen years overlap with the typical onset of the second wave of cardiomyopathy:
- Annual echocardiogram
- Annual EKG
- Cardiac MRI every 2–3 years in many centers
- Cardiopulmonary exercise testing in some centers
- Holter monitor if symptoms suggest arrhythmia
Surveillance may intensify if any signs of restrictive physiology, declining function, or arrhythmia appear.
Adults (18+)
Adult monitoring continues lifelong:
- Annual echocardiogram
- Annual EKG
- Cardiac MRI every 2–3 years
- Holter monitoring as needed
- BNP or NT-proBNP (heart failure blood markers) periodically
- Heart failure medication review and adjustment
Adults who have developed significant cardiomyopathy may have more frequent monitoring — every 3–6 months for echocardiograms in some cases.
Special situations requiring additional monitoring
Acute illness or surgery
Any significant illness, surgery, or hospitalization warrants reassessment. Stress on the heart can worsen subclinical cardiomyopathy.
Pregnancy
Women with Alström who are pregnant need close cardiac surveillance — at least monthly echocardiograms during pregnancy, with delivery planned at a center with cardiac and high-risk obstetric expertise.
New symptoms
Any new symptoms — exercise intolerance, breathlessness, swelling, palpitations, fatigue — warrant earlier evaluation regardless of when the last surveillance visit occurred.
Medication changes
Starting or stopping heart medications often warrants a follow-up echo within 3–6 months to confirm stability.
What each test shows
Echocardiogram
- Chamber size and wall thickness
- Pumping function (ejection fraction)
- Diastolic function (how the heart fills)
- Valve function
- Pericardial effusion (fluid around the heart)
EKG
- Heart rhythm and rate
- Electrical conduction
- Signs of strain or hypertrophy
- Ischemic changes
Cardiac MRI
- Detailed imaging of heart muscle and chambers
- Tissue characterization (fibrosis, inflammation)
- Quantitative measurements that complement echo
- Particularly useful for tracking subtle changes
Holter monitor
- Continuous EKG over 24–48 hours
- Captures intermittent arrhythmias missed on a single EKG
- Correlates symptoms with rhythm events
Cardiopulmonary exercise testing
- Objective measurement of exercise capacity
- Useful for detecting subtle cardiopulmonary limitations
- Helpful for tracking changes over time
What to bring to cardiac visits
- Prior echocardiogram, EKG, and MRI reports (digital or paper)
- Current medication list including doses
- Daily weight log if you're keeping one
- List of any new symptoms or concerns
- Recent diabetes-related labs (HbA1c) — relevant for cardiovascular risk
Coordinating cardiology with the broader Alström team
Your cardiology team should be aware of:
- Diabetes management
- Kidney function (affects medication dosing)
- Liver function (affects medication metabolism)
- Sleep apnea status (affects cardiac demand)
- Any new medications across specialties
Multidisciplinary Alström clinics handle this coordination directly. Otherwise, the family or a coordinating clinician helps bridge.
Common questions
Frequently asked questions
Short answers grounded in the article and the underlying references, so families can quickly understand the main point without losing the medical meaning.
Question
Should I see a cardiologist who specializes in Alström?
Answer
A pediatric or adult cardiologist familiar with Alström or with heart failure in young people is ideal. Many centers of excellence have cardiologists with specific Alström experience. Local cardiology can manage day-to-day care with periodic specialist input.
Question
Are echocardiograms safe to repeat annually?
Answer
Yes — echo uses ultrasound, no radiation. Annual repetition is routine and safe. Cardiac MRI also avoids radiation.
Question
What if we miss a surveillance appointment?
Answer
Reschedule as soon as possible. A delayed echocardiogram is usually fine if there are no symptoms; if symptoms have emerged in the interim, more urgent evaluation is appropriate.
Question
Will my insurance cover this surveillance?
Answer
Annual cardiac surveillance for Alström is medically appropriate and typically covered. If a particular study is denied, your cardiologist can submit a letter of medical necessity citing the consensus guidelines.